Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

29.36
+0.74502.60%
Post-market: 29.450.0900+0.31%16:31 EDT
Volume:4.44M
Turnover:131.45M
Market Cap:3.30B
PE:-25.46
High:30.28
Open:29.19
Low:29.09
Close:28.62
Loading ...
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2022

Major Issues Report

8-K - Current report
Oct 26, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2022

Major Issues Report

8-K - Current report
Jul 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 26, 2022

Major Issues Report

8-K - Current report